<?xml version="1.0" encoding="UTF-8"?>
<p id="para2310">Similar to China, NAFLD is an important cause of liver disease-related mortality in India. The GHE 2015 dataset documented that NAFLD and other causes accounted for 10·9% of all deaths due to cirrhosis and other chronic liver diseases, and for 9·6% of all deaths due to liver cancer (
 <xref rid="tbl2" ref-type="table">table 2</xref>).
 <xref rid="bib1" ref-type="bibr">
  <sup>1</sup>
 </xref> Risk of developing NAFLD is influenced by several environmental and metabolic factors, including obesity, type 2 diabetes, and physical inactivity, which are common in the Indian population.
 <xref rid="bib191" ref-type="bibr">
  <sup>191</sup>
 </xref> In the general population, according to community-based studies, the prevalence of NAFLD on ultrasonography in urban areas was 18·9% in 2007 and 32·0% in 2009,
 <xref rid="bib192" ref-type="bibr">192</xref>, 
 <xref rid="bib193" ref-type="bibr">193</xref> and in rural areas was 8·7% in 2010 and 30·7% in 2016.
 <xref rid="bib194" ref-type="bibr">194</xref>, 
 <xref rid="bib195" ref-type="bibr">195</xref> In urban, hospital-based studies, this prevalence was 25·3% in 2012 and 32·2% in 2009.
 <xref rid="bib196" ref-type="bibr">196</xref>, 
 <xref rid="bib197" ref-type="bibr">197</xref> The prevalence is higher in high-risk groups, such as people with type 2 diabetes (10·5–88%)
 <xref rid="bib198" ref-type="bibr">198</xref>, 
 <xref rid="bib199" ref-type="bibr">199</xref> or obese people (50–80%).
 <xref rid="bib192" ref-type="bibr">192</xref>, 
 <xref rid="bib200" ref-type="bibr">200</xref> 11–32% of patients with NAFLD had a normal body-mass index (BMI).
 <xref rid="bib201" ref-type="bibr">
  <sup>201</sup>
 </xref>
</p>
